APA (7th ed.) Citation

Piero L Olliaro, Annette C Kuesel, Christine M Halleux, Mark Sullivan, & John C Reeder. (2018). Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Piero L Olliaro, Annette C Kuesel, Christine M Halleux, Mark Sullivan, and John C Reeder. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science (PLoS), 2018.

MLA (9th ed.) Citation

Piero L Olliaro, et al. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science (PLoS), 2018.